What are the aims of the Dangerous Drugs Board?
The DDB was mandated to be the policy-making and coordinating agency as well as the national clearing house on all matters pertaining to law enforcement and control of dangerous drugs; treatment and rehabilitation of drug dependents; drug abuse prevention, training and information; research and statistics on the drug …
What countries are drugs legal in?
Czechia, the Netherlands, Portugal and Switzerland are among a handful of countries that have decriminalized drug use and possession for personal use and that have also invested in harm reduction programmes.
How many drug users are in the Philippines?
However, according to the Philippine Dangerous Drugs Board, the government drug policy-making body, 1.8 million Filipinos used illegal drugs (mostly cannabis) in 2015, the latest official survey published, a third of whom had used illegal drugs only once in the past 13 months.
What countries is CBD legal?
The Legal Landscape in 2020
|Country||CBD Legal Staus|
|Belgium||Legal grey area (restricted lean)|
|Czech Republic||Legal grey area (legal lean)|
|Croatia||Legal grey area (legal lean)|
What is difference between legalization and decriminalization?
Legalization of cannabis is the process of removing all legal prohibitions against it. Decriminalization of cannabis means it would remain illegal, but the legal system would not prosecute a person for possession under a specified amount.
What is drug education Brainly?
Drug education is the planned provision of information, resources, and skills relevant to living in a world where psychoactive substances are widely available and commonly used for a variety of both medical and non-medical purposes, some of which may lead to harms such as overdose, injury, infectious disease.
How do drugs affect the economy?
Economic Costs $120 billion in lost productivity, mainly due to labor participation costs, participation in drugabuse treatment, incarceration, and premature death; $11 billion in healthcare costs – for drug treatment and drug‐related medical consequences; and.